Horizon expands agreement with Roche Diagnostics
Cambridge, UK-based Horizon Discovery has expanded its relationship with Roche Diagnostics with a new agreement to assist in the development of immunohistochemistry (IHC) assays.
Read More
Tag: Horizon Pharma
Scotland approves three new meds for NHS use
The Scottish Medicines Consortium (SMC) has published new advice accepting three new medicines for use by NHS Scotland, offering patients new treatment options for soft tissue sarcoma, acromegaly and hepatitis C
Read More
Horizon Pharma enrolls first patient in TED trial
Horizon Pharma has enrolled the first patient in a Phase III clinical trial assessing its experimental medicine teprotumumab for moderate-to-severe active thyroid eye disease (TED).
Read More
Horizon picks up interferon gamma-1b rights from Boehringer
Dublin-Ireland based biopharma Horizon Pharma has bagged rights to Boehringer Ingelheim’s interferon gamma-1b in an around 30 countries primarily in Europe and the Middle East for 25 million euros.
Read More
- Lundbeck completes patient randomisation early in global MSA trial
- Incyte treatment for advanced anal cancer approved in Europe
- HUTCHMED begins global trial of novel attc therapy hmpl‑a580 in solid tumours
- Theolytics awarded €8 million Horizon Europe grant to fund ovarian cancer study
- AI system aims to uncover Alzheimer’s earlier and take on diagnostic delays
